Does performing a Point-Of-Care HbA1c test increase the chances of undertaking an OGTT among individuals at risk of diabetes? A randomized controlled trial.

Autor: Castaño RA; [UEB] Universidad El Bosque, Faculty of Medicine, Bogotá. Colombia., Granados MA; [CAIMED] Centro de Atención e Investigación Médica, Chía, Colombia., Trujillo N; [CAIMED] Centro de Atención e Investigación Médica, Chía, Colombia., Bernal JP; [CAIMED] Centro de Atención e Investigación Médica, Chía, Colombia., Trujillo JF; [CAIMED] Centro de Atención e Investigación Médica, Chía, Colombia., Trasmondi P; [CAIMED] Centro de Atención e Investigación Médica, Chía, Colombia., Maestre AF; [CAIMED] Centro de Atención e Investigación Médica, Chía, Colombia. Electronic address: angelmaestree@gmail.com., Cardona JS; [CAIMED] Centro de Atención e Investigación Médica, Chía, Colombia., Gonzalez R; [CAIMED] Centro de Atención e Investigación Médica, Chía, Colombia., Larrarte MA; [CAIMED] Centro de Atención e Investigación Médica, Chía, Colombia., Hernandez DC; [CAIMED] Centro de Atención e Investigación Médica, Chía, Colombia., Barengo NC; [HWCM] Department of Medical Education, Herbert Wertheim College of Medicine, Florida International University, Miami, FL, USA; [UNMdP] Escuela Superior de Medicina, Universidad Nacional de Mar del Plata, Mar del Plata, Argentina., Reynales H; [CAIMED] Centro de Atención e Investigación Médica, Chía, Colombia.
Jazyk: angličtina
Zdroj: Primary care diabetes [Prim Care Diabetes] 2024 Dec; Vol. 18 (6), pp. 624-631. Date of Electronic Publication: 2024 Sep 23.
DOI: 10.1016/j.pcd.2024.09.005
Abstrakt: Aims: Early detection of type 2 diabetes mellitus is key to reducing micro and macrovascular complications associated with this disease. However, a lab-based process for diagnosis entails the risk of loss-to-follow-up. The objective of this study was to demonstrate if performing a point-of-care test of HbA1c immediately after a screening questionnaire will increase the proportion of individuals showing up for a lab-based confirmatory test as Point-of-care (POC) provides immediate availability, which is expected to reduce loss-to-follow-up.
Research Design and Methods: This trial was a two-arm, randomized controlled, open-label study. Participants were recruited using the FINDRISC Score in a primary care and community setting. All 902 eligible participants were randomized into the intervention (n=511) and control (n=391) group. The intervention group was given information on healthy lifestyles, and a Point-of-care POC-HbA1c test was performed during the same visit. The control group was only given information on healthy lifestyles. Participants in both groups received a written prescription to have an oral glucose tolerance test (OGTT) performed within the next 30 days. Follow-up phone calls were made at 30 and 90 days to check if participant had undergone the test. The total duration of the intervention was 8 months. The posterior data analysis was made by using the Kolmogorov-Smirnoff test for the quantitative variables, and the descriptive statistics were expressed as means and standard deviation, or median and interquartile range 25 %-75 %, as appropriate.
Results: At 30 days, 28 % of participants in the intervention group and 26.1 % in the control group undertook the OGTT (RD 1.90 %; 95 % CI -3.94; 7.73). At 90 days, 35.8 % of participants in the intervention group and 37.1 % in the control group undertook the OGTT. There was no statistically significant difference (RD - 3.17 %; 95 % CI -7.04; 0.70) between both groups.
Conclusions: The data suggest that performing a POC-HbA1c test after the FINDRISC did not increase the percentage of individuals showing up for the OGTT.
Competing Interests: Declaration of Competig Interest The author Ramon A. Castaño indicates that he received consultancy fees on issues related to diabetes from Abbot Diagnostics, Novo Nordisk and Sanofi. The rest of the authors declare that they have no conflict of interest.
(Copyright © 2024 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights reserved.)
Databáze: MEDLINE